Details for New Drug Application (NDA): 212563
✉ Email this page to a colleague
NDA 212563 describes FERRIC CITRATE, which is a drug marketed by Teva Pharms Usa and is included in one NDA. It is available from one supplier. Additional details are available on the FERRIC CITRATE profile page.
The generic ingredient in FERRIC CITRATE is ferric citrate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ferric citrate profile page.
The generic ingredient in FERRIC CITRATE is ferric citrate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ferric citrate profile page.
Summary for 212563
| Tradename: | FERRIC CITRATE |
| Applicant: | Teva Pharms Usa |
| Ingredient: | ferric citrate |
| Patents: | 0 |
Pharmacology for NDA: 212563
| Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 212563
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FERRIC CITRATE | ferric citrate | TABLET;ORAL | 212563 | ANDA | Teva Pharmaceuticals, Inc. | 0480-2996 | 0480-2996-97 | 200 TABLET, FILM COATED in 1 BOTTLE (0480-2996-97) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 210MG IRON | ||||
| Approval Date: | Mar 11, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
